Hiv

HIV vaccine trial launches in South Africa

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental ...

Feb 18, 2015
popularity 5 / 5 (2) | comments 0

Elucidating the origin of MDR tuberculosis strains

A study has focused on the evolutionary history of the mycobacterium that causes tuberculosis, and more specifically on the Beijing lineage associated with the spread of multidrug resistant forms of the disease ...

Jan 29, 2015
popularity 5 / 5 (1) | comments 0

Health insurers using drug coverage to discriminate

Some insurers offering health plans through the new federal marketplace may be using drug coverage decisions to discourage people with HIV from selecting their plans, according to a new study from Harvard ...

Jan 28, 2015
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

Study shows who benefits most from statins

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers ...

Protein may be key to cancer's deadly resurgences

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently ...